3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
14
Neoplasms
6
Colonic Neoplasms
5
Agnosia
5
Lung Neoplasms
4
Head and Neck Neoplasms
4
Cancer Pain
4
Breast Neoplasms
4
Rectal Neoplasms
3
Prostatic Neoplasms
3
Pain, Postoperative
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Pancreatic Neoplasms
2
Lymphoma, Follicular
2
Diverticulosis, Colonic
2
Chronic Pain
2
Breakthrough Pain
2
post laminectomy syndrome
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Terminal Cancer
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Interventions
Dexamethasone
5
ramosetron
3
Ondansetron
2
Calcium Dobesilate
2
Acupuncture Therapy
2
phenazine
1
esmolol
1
Therapeutics
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Olanzapine
1
Gelatin
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Aprepitant
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Adrenergic beta-Antagonists
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Postoperative Nausea and Vomiting
×
Fentanyl
×
Clear all
NCT01544959
2018-10-24
PAINFree
Université de Sherbrooke
Phase NA
Completed
84 enrolled